This company has been marked as potentially delisted and may not be actively trading. RXi Pharmaceuticals (RXII) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock RXII vs. LNAI, TAOX, NNVC, EGRX, IBIO, AEON, NRBO, OBSV, CPHI, and GRAYShould you be buying RXi Pharmaceuticals stock or one of its competitors? The main competitors of RXi Pharmaceuticals include Lunai Bioworks (LNAI), Synaptogenix (TAOX), NanoViricides (NNVC), Eagle Pharmaceuticals (EGRX), Ibio (IBIO), AEON Biopharma (AEON), NeuroBo Pharmaceuticals (NRBO), ObsEva (OBSV), China Pharma (CPHI), and Graybug Vision (GRAY). RXi Pharmaceuticals vs. Its Competitors Lunai Bioworks Synaptogenix NanoViricides Eagle Pharmaceuticals Ibio AEON Biopharma NeuroBo Pharmaceuticals ObsEva China Pharma Graybug Vision Lunai Bioworks (NASDAQ:LNAI) and RXi Pharmaceuticals (NASDAQ:RXII) are both small-cap pharmaceutical preparations industry companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership. Does the media prefer LNAI or RXII? In the previous week, Lunai Bioworks' average media sentiment score of 0.00 equaled RXi Pharmaceuticals'average media sentiment score. Company Overall Sentiment Lunai Bioworks Neutral RXi Pharmaceuticals Neutral Which has more risk and volatility, LNAI or RXII? Lunai Bioworks has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, RXi Pharmaceuticals has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500. Do institutionals and insiders have more ownership in LNAI or RXII? 71.4% of Lunai Bioworks shares are owned by institutional investors. Comparatively, 9.6% of RXi Pharmaceuticals shares are owned by institutional investors. 0.5% of Lunai Bioworks shares are owned by insiders. Comparatively, 1.0% of RXi Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher valuation & earnings, LNAI or RXII? RXi Pharmaceuticals has higher revenue and earnings than Lunai Bioworks. RXi Pharmaceuticals is trading at a lower price-to-earnings ratio than Lunai Bioworks, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLunai BioworksN/AN/A-$178.01M-$7.70-0.16RXi Pharmaceuticals$10K924.18-$12.45M-$4.20-0.50 Is LNAI or RXII more profitable? Lunai Bioworks has a net margin of 0.00% compared to RXi Pharmaceuticals' net margin of -4,990.20%. Lunai Bioworks' return on equity of -222.12% beat RXi Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Lunai BioworksN/A -222.12% -152.88% RXi Pharmaceuticals -4,990.20%-412.15%-179.54% Do analysts prefer LNAI or RXII? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lunai Bioworks 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00RXi Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryLunai Bioworks beats RXi Pharmaceuticals on 6 of the 11 factors compared between the two stocks. Get RXi Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RXII and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RXII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RXII vs. The Competition Export to ExcelMetricRXi PharmaceuticalsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.24M$1.08B$6.19B$10.57BDividend YieldN/A4.84%5.72%4.81%P/E Ratio-0.501.3085.5427.12Price / Sales924.1829.96610.04131.73Price / CashN/A17.6337.1060.81Price / Book2.748.0712.236.52Net Income-$12.45M-$7.36M$3.33B$276.93M RXi Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RXIIRXi PharmaceuticalsN/A$2.11-0.5%N/A-34.8%$9.24M$10K-0.50N/ALNAILunai BioworksN/A$1.26+3.3%N/AN/A$29.21MN/A-0.1620News CoverageTAOXSynaptogenix0.0617 of 5 stars$8.26-14.0%N/AN/A$28.80M$3.96K-0.414News CoverageGap UpNNVCNanoViricides0.8158 of 5 stars$1.33-1.5%N/A+0.7%$23.18MN/A-1.8520News CoverageShort Interest ↓EGRXEagle Pharmaceuticals2.0677 of 5 stars$1.50flatN/A+130.8%$19.48M$257.55M0.00100IBIOIbio1.0317 of 5 stars$0.82+2.5%N/AN/A$16.61M$400K-0.47100Analyst UpgradeShort Interest ↓AEONAEON Biopharma0.5331 of 5 stars$1.14-3.0%N/A-98.6%$13.17MN/A6.285Gap DownNRBONeuroBo PharmaceuticalsN/A$0.99+1.3%N/A-67.1%$8.54MN/A0.0010Gap UpOBSVObsEvaN/AN/AN/AN/A$7.94MN/A0.0050CPHIChina Pharma0.153 of 5 stars$1.90+1.1%N/A-92.3%$6.18M$4.40M0.00250Short Interest ↑GRAYGraybug VisionN/A$3.26+3.0%N/A-21.5%$5.12MN/A-1.8827High Trading Volume Related Companies and Tools Related Companies LNAI Alternatives TAOX Alternatives NNVC Alternatives EGRX Alternatives IBIO Alternatives AEON Alternatives NRBO Alternatives OBSV Alternatives CPHI Alternatives GRAY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RXII) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredElon’s Optimus to mint new “Musk Millionaires” as soon as Oct 23???Elon Musk may be set to create more "Musk Millionaires" as soon as October 23rd… Because on that day, he's exp...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe “smart money” is piling into one AI power company.Expert Reveals: The #1 Energy Play for 2025 "We're Entering the Greatest Energy Bull Market Since the Indus...Brownstone Research | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RXi Pharmaceuticals Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share RXi Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
